FundamentalVR secures three-year follow on order

RNS Number : 2346G
Tern PLC
24 November 2020
 

REACH

 

24 November 2020

 

Tern Plc

("Tern" or the "Company")

 

FundamentalVR secures three-year follow on order with global pharma company

 

Tern Plc (AIM:TERN), the investment company specialising in the Internet of Things ("IoT"), is pleased to announce that its portfolio company, FVRVS Limited ("FundamentalVR"), has recently secured a three year contract worth £0.4 million from an existing client, which is a global pharmaceutical company ("the Client"), to accelerate the safe and compliant use of the Client's product.

 

The contract will deliver recurring annual revenues over its three-year term from licences and support, to enable a global rollout of the Client's training solution using FundamentalVR's Fundamental Surgery virtual reality platform.  This contract follows on from an initial £0.5 million contract from the Client announced in December 2019. The rollout of the virtual reality simulation is intended to deliver the Client's ambitions to accelerate the safe and compliant use of their products by using FundamentalVR's unique HapticVR TM technology.

 

Al Sisto, Tern CEO, said: "We are delighted to see that FundamentalVR has secured this significant follow-on contract from a global pharmaceutical company.  This contract follows the successful completion of the initial configuration of the Fundamental Surgery platform for the Client.

 

"FundamentalVR has made significant progress during 2020 and is working with a variety of companies to implement its immersive, data driven medical educational simulations for other pharma company applications, as well as those in the orthopaedic and ophthalmology areas. We look forward to reporting on further developments at FundamentalVR and with our other portfolio companies in due course."

 

Enquiries

 

Tern Plc

Al Sisto (CEO)

Sarah Payne (CFO)

via IFC Advisory

 

Allenby Capital Limited

(Nominated Adviser and Broker)

David Worlidge / Alex Brearley (Corporate Finance)

Guy McDougall (Equity Sales)

 

Tel: 0203 328 5656

 

 

 

IFC Advisory

(Financial PR and IR)

Tim Metcalfe

Graham Herring

Florence Chandler

 

Tel: 0203 934 6630

tern@investor-focus.co.uk

 

About FundamentalVR

 

FundamentalVR delivers VR haptic 'flight simulators' for surgery creating a safe, measurable and repeatable space to refine skills.  FundamentalVR's goal is to transform the way surgeons prepare, practice, and refine their skills. It has built an immersive, surgical simulation application platform, Fundamental Surgery , to provide medical professionals with the opportunity to rehearse, practice, and test themselves within a safe, controllable space that is as close to real-life as possible.

 

Tern's shareholding in FundamentalVR is 26.9% and as at 30 June 2020 this holding had a book valuation of £3.0 million.

 

About Reach announcements

 

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABRBDBBGDDGGX

Companies

Tern (TERN)
UK 100

Latest directors dealings